Trial Profile
Investigation of clinical efficacy of Enzalutamide and its predictive factors in CRPC patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2020
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics; Therapeutic Use
- 19 Nov 2020 Status changed from recruiting to completed.
- 07 Oct 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 27 Dec 2014 New trial record